Abstract
There has been considerable debate about the utility of prognostic factors for breast cancer; yet, in one way or another they are routinely used by many physicians and patients every day to make a variety of decisions. We concentrate here on three areas in which the decision-making process could be improved by a better understanding of prognostic factors: (a) identification of women who will eventually develop breast cancer, (b) prediction of clinical outcome of patients who have been diagnosed with breast cancer, (c) prediction of benefit from adjuvant therapy for specific breast cancer patients.
William L. McGuire was a Clinical Research Professor of the American Cancer Society until his death on March 25, 1992. Supported in part by NIH Grant CA30195.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Page DL, Dupont WD (1990) Premalignant conditions and markers of elevated risk in the breast and their management. Surg Clin North Am 70:831–851
McGuire WL (1988) Adjuvant therapy of node-negative breast cancer: another point of view. J Natl Cancer Inst 80:1075–1076
McGuire WL (1989) Adjuvant therapy of node-negative breast cancer. N Engl J Med 320:525–527
Early Breast Cancer Trialists’ Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet: 1–15, 71–85
Ravdin PM, Hilsenbeck SG, Clark GM et al. (1991) Comparison of neural network analysis and Cox modeling for predicting relapse of axillary node positive breast cancer patients (Abstr). Proc Am Soc Clin Oncol 10:47
McGuire WL, Tandon AK, Allred DC et al. (1990) How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 82:1006–1015
McGuire WL (1991) Guidelines for evaluating new prognostic factors. J Natl Cancer Inst 83:154–155
Clark GM, Dressier LG, Owens MA et al. (1989) Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320:627–633
Bustamante-Montes MA, Clark G, Langone G et al. (1989) Histopathological grading of breast specimens correlates with disease-free survival in node-negative breast cancer patients (Abstr). Proc Am Assoc Cancer Res 30:252
Tandon AK, Clark GM, Chamness GC et al. (1990) Cathepsin D and prognosis in breast cancer. N Engl J Med 322:297–301
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Clark, G.M., McGuire, W.L. (1993). Prognosis of Breast Cancer Patients: How To Use What?. In: Senn, HJ., Gelber, R.D., Goldhirsch, A., Thürlimann, B. (eds) Adjuvant Therapy of Breast Cancer IV. Recent Results in Cancer Research, vol 127. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84745-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-84745-5_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84747-9
Online ISBN: 978-3-642-84745-5
eBook Packages: Springer Book Archive